Liver Disease in Mitochondrial Disorders

Way S. Lee; Ronald J. Sokol

doi:10.1055/s-2007-985071

Seminars in Liver Disease, Inhaltsverzeichnis

Semin Liver Dis 2007; 27(3): 259-273
DOI: 10.1055/s-2007-985071

Liver Disease in Mitochondrial Disorders

Way S. Lee¹ ^, ² , Ronald J. Sokol²

¹Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur, Malaysia
²Section of Pediatric Gastroenterology, Hepatology, and Nutrition, and Clinical Translational Research Center, University of Colorado School of Medicine and The Children's Hospital, Denver, Colorado

Abstract

ABSTRACT

Liver involvement, a common feature in childhood mitochondrial hepatopathies, particularly in the neonatal period, may manifest as neonatal acute liver failure, hepatic steatohepatitis, cholestasis, or cirrhosis with chronic liver failure of insidious onset. There are usually significant neuromuscular symptoms, multisystem involvement, and lactic acidemia. The liver disease is usually progressive and eventually fatal. Current medical therapy of mitochondrial hepatopathies is largely ineffective, and the prognosis is usually poor. The role of liver transplantation in patients with liver failure remains poorly defined because of the systemic nature of the disease that does not respond to transplantation. Several specific molecular defects (mutations in nuclear genes such as SCO1, BCS1L, POLG, DGUOK, and MPV17 and deletion or rearrangement of mitochondrial DNA) have been identified in recent years. Prospective, longitudinal multicenter studies will be needed to address the gaps in our knowledge in these rare liver diseases.

KEYWORDS

Mitochondrial hepatopathies - genetics - pathogenesis

Volltext

Referenzen

REFERENCES

1 Chinnery P F, DiMauro S. Mitochondrial hepatopathies. J Hepatol. 2005; 43 207-209
2 Sokol R J, Treem W R. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr. 1999; 28 4-16
3 DiMauro S, Schon E A. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003; 348 2656-2668
4 Johns D R. Mitochondrial DNA and disease. N Engl J Med. 1995; 333 638-644
5 Morris A A, Taanman J W, Blake J et al.. Liver failure associated with mitochondrial DNA depletion. J Hepatol. 1998; 28 556-563
6 Labarthe F, Dobbelaere D, Devisme L et al.. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J Hepatol. 2005; 43 333-341
7 Sutovsky P, Moreno R D, Ramalho-Santos J, Dominko T, Simerly C, Schatten G. Ubiquitin tag for sperm mitochondria. Nature. 1999; 402 371-372
8 Sutovsky P, Van Leyen K, McCauley T, Day B N, Sutovsky M. Degradation of paternal mitochondria after fertilization: implications for heteroplasmy, assisted reproductive technologies and mtDNA inheritance. Reprod Biomed Online. 2004; 8 24-33
9 Skladal D, Halliday J, Thornburn D R. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain. 2003; 126 1905-1912
10 Darin N, Oldfors A, Moslemi A R, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol. 2001; 49 377-383
11 Cormier-Daire V, Chretien D, Rustin P et al.. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr. 1997; 130 817-822
12 Garcia-Cazorla A, De Lonlay P, Nassogne M C, Rustin P, Touati G, Saudubray J M. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics. 2005; 116 1170-1177
13 Holve S, Hu D, Shub M, Tyson R W, Sokol R J. Liver disease in Navajo neuropathy. J Pediatr. 1999; 135 482-493
14 Leonard J V, Shapiro A HV. Mitochondrial respiratory chain disorders. I: mitochondrial DNA defects. Lancet. 2000; 355 299-304
15 Von Kleist-Retzow J C, Cormier-Daire V, Viot G et al.. Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr. 2003; 143 208-212
16 Moraes C T, Shanske S, Tritschler H J et al.. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991; 48 492-501
17 Bakker H D, Scholte H R, Dingemans K P, Spelbrink J N, Wijburg F A, Van der Bogert C. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease. J Pediatr. 1996; 128 683-687
18 Narkewicz M R, Sokol R J, Beckwith B, Sondheimer J, Silverman A. Liver involvement in Alpers disease. J Pediatr. 1991; 119 260-267
19 Boyd S G, Harden A, Egger J, Pampiglione G. Progressive neuronal degeneration of childhood with liver disease (“Alpers' disease”): characteristic neurophysiological features. Neuropediatrics. 1986; 17 75-80
20 Tzoulis C, Engelsen B A, Telstad W et al.. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain. 2006; 129 1685-1692
21 Harding B N. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol. 1990; 5 273-287
22 Egger J, Harding B N, Boyd S G, Wilson J, Erdohazi M. Progressive neuronal degeneration of childhood (PNDC) with liver disease. Clin Pediatr (Phila). 1987; 26 167-173
23 Gauthier-Villars M, Landrieu P, Cormier-Daire V et al.. Respiratory chain deficiency in Alpers syndrome. Neuropediatrics. 2001; 32 150-152
24 Pearson H A, Lobel J S, Kocoshis S A et al.. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979; 95 976-984
25 Morikawa Y, Matsuura N, Kakudo K, Higuchi R, Koike M, Kobayashi Y. Pearson's marrow/pancreas syndrome: a histological and genetic study. Virchows Arch A Pathol Anat Histopathol. 1993; 423 227-231
26 Krahenbuhl S, Kleinle S, Henz S et al.. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome. J Hepatol. 1999; 31 550-555
27 Majander A, Suomalainen A, Vettenranta K et al.. Congenital hypoplastic anemia, diabetes, and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res. 1991; 30 327-330
28 Cormier-Daire V, Bonnefont J P, Rustin P et al.. Mitochondrial DNA rearrangement with onset as chronic diarrhea with villous atrophy. J Pediatr. 1994; 124 63-70
29 Singleton R, Helgerson S D, Snyder R D et al.. Neuropathy in Navajo children: clinical and epidemiologic features. Neurology. 1990; 40 363-367
30 Robinson B H. Lactic acidemia and mitochondrial disorders. Mol Genet Metab. 2006; 89 3-13
31 Kreisberg R A. Glucose-lactate inter-relations in man. N Engl J Med. 1972; 287 132-137
32 Rustin P, Chretien D, Bourgeron T et al.. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta. 1994; 228 35-51
33 Holt I J, Harding A E, Morgan-Hughes J A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988; 331 717-719
34 Cormier V, Rustin P, Bonnefont J P et al.. Hepatic failure in disorders of oxidative phosphorylation with neonatal onset. J Pediatr. 1991; 119 951-954
35 Bohm M, Pronicka E, Karczmarewicz E et al.. Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency. Pediatr Res. 2006; 59 21-26
36 Taanman J W. Human cytochrome c oxidase: structure, function, and deficiency. J Bioenerg Biomembr. 1997; 29 151-163
37 Valnot I, Osmond S, Gigarel N et al.. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet. 2000; 67 1104-1109
38 Sacconi S, Salviati L, Sue C M et al.. Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res. 2003; 53 224-230
39 De Lonlay P, Valnot I, Barrientos A et al.. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet. 2001; 29 57-60
40 De Meirleir L, Seneca S, Damis E et al.. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am J Med Genet A. 2003; 121 126-131
41 Moraes C T, Shanske S, Tritschler H J et al.. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991; 48 492-501
42 Jullig M, Eriksson S. Mitochondrial and submitochondrial localization of human deoxyguanosine kinase. Eur J Biochem. 2000; 267 5466-5472
43 Wang L, Munch-Petersen B, Herrstrom Sjoberg A et al.. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett. 1999; 443 170-174
44 Mandel H, Szargel R, Labay V et al.. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001; 29 337-341
45 Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001; 29 342-344
46 Salviati L, Sacconi S, Mancuso M et al.. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol. 2002; 52 311-317
47 Ferrari G, Lamantea E, Donati A et al.. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA. Brain. 2005; 128 723-731
48 Horvath R, Hudson G, Ferrari G et al.. Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Brain. 2006; 129 1674-1684
49 Spinazzola A, Viscomi C, Fernandez-Vizarra E et al.. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 2006; 38 570-575
50 Naviaux R K, Nguyen K V. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol. 2004; 55 706-712
51 Nguyen K V, Sharief F S, Chan S SL, Copeland W C, Naviaux R K. Molecular diagnosis of Alpers syndrome. J Hepatol. 2006; 45 108-116
52 Kaguni L S. DNA polymerase γ: the mitochondrial replicase. Annu Rev Biochem. 2004; 73 293-320
53 Naviaux R K, Nyhan W L, Barshop B A et al.. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol. 1999; 45 54-58
54 Lamantea E, Tiranti V, Bordoni A et al.. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol. 2002; 52 211-219
55 Vu T H, Tanji K, Holve S A et al.. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome?. Hepatology. 2001; 34 116-120
56 Karadimas C L, Vu T H, Holve S A et al.. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet. 2006; 79 544-548
57 Rotig A, Cormier V, Blanche S et al.. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest. 1990; 86 1601-1608
58 Sano T, Ban K, Ichiki T et al.. Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome. Pediatr Res. 1993; 34 105-110
59 Jacobs LJAM, Jongbloed R JE, Wijburg F A et al.. Pearson syndrome and the role of deletion dimers and duplications in the mtDNA. J Inherit Metab Dis. 2004; 27 47-55
60 MITOMAP .A Human Mitochondrial Genome Database. Atlanta, GA; Center for Molecular Medicine, Emory University http://Available at: www.mitomap.org Accessed October 24, 2006
61 Muraki K, Sakura N, Ueda H, Kihara H, Goto Y. Clinical implications of duplicated mtDNA in Pearson syndrome. Am J Med Genet. 2001; 98 205-209
62 Gillis L A, Sokol R J. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am. 2003; 32 789-817
63 Chinnery P, Majamaa K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders (review). Cochrane Database Syst Rev. 2006; (1) CD004426
64 Mahoney D J, Parise G, Tarnopolsky M A. Nutritional and exercise-based therapies in the treatment of mitochondrial disease. Curr Opin Clin Nutr Metab Care. 2002; 5 619-629
65 Hart P E, Lodi R, Rajagopalan B et al.. Antioxidant treatment of patients with Freidreich ataxia: four year follow-up. Arch Neurol. 2005; 62 621-626
66 Eleff S, Kennaway N G, Buist N R et al.. 31P NMR study of improvement in oxidative phosphorylation by vitamin K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA. 1984; 81 3529-3533
67 Chen R S, Huang C C, Chu N S. Coenzyme Q10 treatment in mitochondrial encephalomyopathies: short-term double-blind, crossover study. Eur Neurol. 1997; 37 212-218
68 Muller W, Reimers C D, Berninger T et al.. Coenzyme Q10 in ophthalmoplegia plus: a double blind, cross over therapeutic trial. J Neurol Sci. 1990; 98(suppl) 442
69 Frei B, Kim M C, Ames B N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA. 1990; 87 4879-4883
70 Rodriguez M C, MacDonald J R, Mahoney D J, Parise G, Beal M F, Tarnopolsky M A. Beneficial effects of creatinine, CoQ(10), and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007; 35 235-242
71 Rustin P, Bonnet D, Rotiq A, Munnich A, Sidi D. Idebenone treatment in Freidreich patients: one-year-long randomized placebo-controlled trial. Neurology. 2004; 62 524-525
72 Di Rocco M, Lamba L D, Minniti G, Caruso U, Naito E. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency. Eur J Paediatr Neurol. 2000; 4 115-117
73 Bugiani M, Lamantea E, Invernizzi F et al.. Effects of riboflavin in children with complex II deficiency. Brain Dev. 2006; 28 576-581
74 Stacpoole P W, Kerr D S, Barnes C et al.. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006; 117 1519-1531
75 Oguro H, Iijima K, Takahashi K et al.. Successful treatment with succinate in a patient with MELAS. Intern Med. 2004; 43 427-431
76 Schols L, Zange J, Abele M et al.. L-carnitine and creatine in Freidreich's ataxia: a randomized, placebo-controlled crossover trial. J Neural Transm. 2005; 112 789-796
77 Kornblum C, Schroder R, Muller K et al.. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol. 2005; 12 300-309
78 Mowat D, Kirby D M, Kamatu K R, Kan A, Thorburn D R, Christodoulou J. Respiratory chain complex III deficiency with pruritus, a novel vitamin responsive clinical feature. J Pediatr. 1999; 134 352-354
79 Sokal E M, Sokol R, Cormier V et al.. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr. 1999; 158(suppl 2) S81-S84
80 Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D A. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr. 1998; 26 478-481
81 Dubern B, Broue P, Dubinsson C et al.. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation. 2001; 71 633-637
82 Delarue A, Paut O, Guys J-M et al.. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant. 2000; 4 67-71
83 Cholestatic Liver Disease Consortium (CLiC) .Available at: http://rarediseasesnetwork.epi.usf.edu/clic/index.htm Accessed February 4, 2007

Ronald J SokolM.D.

Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Box B290, The Children's Hospital

1056 E. 19th Avenue, Denver, CO 80218